Hypoxia, or low oxygen levels, is a common feature of the TME due to the rapid growth of tumor cells outpacing the development of new blood vessels. Hypoxia-inducible factors (HIFs) are transcription factors that respond to low oxygen levels and activate the expression of genes involved in angiogenesis, glycolysis, and cell survival. Hypoxia also promotes a more aggressive tumor phenotype and resistance to therapy.
